심장용 POC 검사 기기 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 검체 유형별, 기기 구성별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Cardiac Poc Testing Devices Market size was valued at USD 2.0 Billion in 2024 and is poised to grow from USD 2.1 Billion in 2025 to USD 3.14 Billion by 2033, growing at a CAGR of 5.12% during the forecast period (2026-2033).

The global cardiac point of care (POC) testing devices market is evolving significantly, centered on portable analyzers that deliver rapid biomarker assessments, such as troponin and cholesterol, at the bedside in acute situations. These technologies notably reduce diagnostic delays for acute coronary syndrome, potentially improving survival rates and minimizing hospital costs. Regulatory approval of rapid cardiac biomarkers facilitates market expansion by establishing reimbursement pathways and enhancing physician confidence. As hospitals invest in these systems, the demand for connectivity solutions that relay results to cardiology dashboards increases, often supported by companies specializing in cloud analytics. Furthermore, artificial intelligence is transforming the market by optimizing sensor outputs, enhancing diagnostic accuracy, and fostering wider adoption across various healthcare settings, including emergency rooms and primary care offices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Poc Testing Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Poc Testing Devices Market Segments Analysis

The global cardiac point-of-care (POC) testing devices market is segmented by product type, technology, sample type, device configuration, end user, distribution channel, and region. Based on product type, the market is segmented into Cardiac Biomarker Test Kits, POC Analyzers, Test Strips & Consumables, and Others. Based on technology, the market is segmented into Immunoassay, Microfluidics, Biosensor-Based Technology, Electrocardiography sensors, and optical spectroscopy. Based on sample type, the market is segmented into Whole Blood, Plasma, Serum, and Others. Based on device configuration, the market is segmented into Portable/Handheld Devices, Benchtop Devices, and integrated cartridge systems. Based on end user, the market is segmented into Hospitals & Emergency Departments, Diagnostic Laboratories, Ambulatory Surgical Centers, Physician Offices & Clinics, Home Healthcare Settings, and Others. Based on distribution channel, the market is segmented into Direct Sales, Distributors & Wholesalers, Online Sales, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Cardiac Poc Testing Devices Market

The rise in cardiovascular cases globally is significantly driving the demand for rapid diagnostic solutions, leading healthcare providers to integrate point-of-care heart testing into standard care practices. Clinicians appreciate receiving immediate results, as this enables quicker treatment decisions, ultimately reducing patient wait times and enhancing overall clinical outcomes. Consequently, hospitals and outpatient clinics are increasingly investing in portable analyzers, further fueling market growth. Additionally, the shift toward decentralized testing aligns with the broader objective of enhancing disease management efficiency, sustaining the positive momentum for the global cardiac point-of-care testing devices market.

Restraints in the Global Cardiac Poc Testing Devices Market

The Global Cardiac Point-of-Care Testing Devices market faces significant challenges due to high costs associated with sophisticated components and rigorous validation processes. This elevated price point can deter budget-constrained facilities from investing in these advanced technologies. Many hospitals prioritize essential equipment under strict spending regulations, which can result in delays when considering newer testing solutions. Furthermore, reimbursement policies in various regions may not adequately reflect the true value of rapid cardiac diagnostics, creating a lack of compelling financial justification for procurement. Consequently, the combination of high initial purchase prices and ongoing maintenance expenses poses a substantial restraint, hindering the overall growth of the market.

Market Trends of the Global Cardiac Poc Testing Devices Market

The Global Cardiac Point of Care Testing (PoCT) Devices market is witnessing a trend towards seamless integration of these devices into existing hospital IT systems. This integration enhances the efficiency of healthcare delivery by allowing instant access to test results within electronic health records and lab information networks. By streamlining clinician workflows and enabling real-time data analytics, the risk of manual transcription errors decreases significantly. Consequently, clinical decision-making is expedited, facilitating smoother coordinated care among multidisciplinary teams. The emphasis on interoperable hardware and open API software is enabling broader adoption of digital diagnostic processes in hospitals and large clinics, ultimately leading to improved patient outcomes through earlier therapeutic interventions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cardiac POC Testing Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Troponin Testing Devices
• BNP Testing Devices
• CK-MB Testing Devices
• Multi-Cardiac Marker Devices
• Others

Global Cardiac POC Testing Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay-Based Devices
• Biosensor-Based Devices
• Microfluidic Devices
• Others

Global Cardiac POC Testing Devices Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Whole Blood
• Plasma
• Serum

Global Cardiac POC Testing Devices Market Size by Device Configuration & CAGR (2026-2033)

• Market Overview
• Benchtop Devices
• Handheld Devices

Global Cardiac POC Testing Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Emergency Departments
• Cardiac Clinics
• Others

Global Cardiac POC Testing Devices Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Medical Device Distributors
• Group Purchasing Organizations

Global Cardiac POC Testing Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Technology, Sample Type, Device Configuration, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Technology, Sample Type, Device Configuration, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Sample Type, Device Configuration, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Sample Type, Device Configuration, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Sample Type, Device Configuration, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Radiometer Medical ApS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boditech Med Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Response Biomedical Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getein Biotech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujirebio Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LumiraDx Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations